PARNAXLABBSEPARNAX LAB LTD.· Pharmaceuticals & BiotechnologyMediumNeutral
Announced Tue, 29 Sept, 2026 · 18:15 IST

Parnax Lab appoints Ladha Singhal & Associates as statutory auditor

PARNAXLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.9%Reaction day
₹112.00
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.3%-0.6% vs market
Pharmaceuticals peers, median of 172sector-0.9%+0.1% vs sector

On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and 0.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.9-0.3-0.6-0.9+0.1
Next day
+2.7-1.5+4.2-1.7+4.4
2d
+0.4-1.5+2.0-2.6+3.1
3d
+3.1-0.2+3.4-1.5+4.6
4d
-0.4-0.5+0.0-1.8+1.3
5d
+0.9-3.2+4.1-3.5+4.4
1w
+0.9-2.2+3.0-4.4+5.3
15d
-7.6-9.5+1.9-9.2+1.6
1m
-2.2pendingpending-6.8+4.5
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Parnax Lab shareholders have approved the appointment of Ladha Singhal and Associates, Chartered Accountants (FRN 120241W) as statutory auditors, replacing retiring auditors C N Patel and Co. The appointment is for a 5-year term from the conclusion of the 44th AGM held on September 29, 2026, until the conclusion of the 49th AGM in 2031. This is a routine rotation as the previous auditors tenure ended. The new firm is based in Mumbai and is not related to any directors.

Likely market impact

Routine auditor rotation with no governance red flags. No material impact expected on shareholders or stock price.